Diflunisal Tablet, Film Coated
NDC Package 14539-673-01
Package Information
Diflunisal tablets is diflunisal is used to relieve mild to moderate pain from various conditions. This formulation utilizes a tablet, film coated delivery system. Marketed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., this product is identified by NDC 14539-673 and is authorized under FDA application ANDA202845.
Identification & Billing
- RxCUI: 197602 - diflunisal 250 MG Oral Tablet
- RxCUI: 197603 - diflunisal 500 MG Oral Tablet
- RxCUI: 249400 - diflunisal 375 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 14539 - Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
- 14539-673 - Diflunisal
- 14539-673-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 14539-673 - Diflunisal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (14539-673). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 14539-673-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Diflunisal, a human prescription drug labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. This tablet, film coated is formulated for oral use and contains diflunisal as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. on March 08, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Diflunisal is used to relieve mild to moderate pain from various conditions. It also reduces pain, swelling, and joint stiffness caused by arthritis. Reducing these symptoms helps you do more of your normal daily activities. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID).
How is this Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 14539067301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.